A

Amgen

Makes biotech medicines for serious illnesses

Global Marketing Director - Oncology

Product MarketingConfirmed live in the last 24 hours
Full-timeRemote in USARemote

About the Job

Requirements

  • A doctorate degree and 2 years of marketing and/or business experience in a role aligned with a Marketing/Sales commercial organization, or a master's degree and 4 years of such experience, or a bachelor's degree and 6 years, or an associate's degree and 10 years, or a high school diploma/GED and 12 years.
  • Preferred: 8+ years of experience with a track record of success in progressively broader and more complex commercial roles at leading biopharmaceutical companies.
  • Preferred: Experience developing and implementing global marketing and commercial strategies for pipeline products, launching therapeutic products, repositioning products, and strategic marketing.
  • Preferred: Strong oncology and solid tumor immuno-oncology experience, including understanding of the science, market trends, opportunities, and hurdles.
  • Preferred: Experience with beyond-the-molecule value drivers such as patient services or the companion diagnostics/in vitro diagnostics space.
  • Preferred: Experience in commercial positions with global responsibilities; experience living and working outside the United States is highly desirable. Understanding of global market dynamics and cultural awareness and sensitivity to build relationships and work effectively with colleagues around the world.
  • Preferred: Broad therapeutic-area expertise across commercial roles, disease states, product lifecycle stages, customer groups, and competitive markets; experience supporting partnered assets or programs.
  • Preferred: Experience in tactical local-market marketing, implementing marketing strategies, and understanding global market access, pricing, and reimbursement.
  • Preferred: Experience leading cross-functional teams in a matrix environment and managing global projects involving multiple functions and shared accountabilities.
  • Preferred: MBA coupled with a life sciences educational background.

Responsibilities

  • Partner strategically with brand and cross-functional teams, independently owning the integrated insight agenda for a pipeline asset, brand, or disease area.
  • Generate business-relevant insights that inform global commercialization planning, brand strategy, lifecycle management, and decision-making.
  • For peri-launch products, including IMDELLTRA (tarlatamab), maximize asset value in key indications, provide commercial guidance and vision, develop global launch strategies, anticipate lifecycle-management opportunities, and optimize marketing-budget impact.
  • Provide commercial leadership to the development organization to ensure IMDELLTRA is developed with the future market in mind and in parallel with late-stage indications.
  • Work with oncology leaders to incorporate insights and market learnings from other thoracic oncology products and peri-launch assets into IMDELLTRA's commercial strategy.
  • Work with the integrated brand team and selected local-country brand working groups to integrate local market insights and support Global-with-Local engagements, including launch readiness plans.
  • Work with the Global Marketing Lead to develop a commercial strategy based on insights into customers, the marketplace, competitors, and business drivers, designed to optimize the future value of IMDELLTRA indications, including limited-stage and extensive-stage front-line indications.
  • Lead marketing deliverables requiring cross-functional stakeholder alignment and input, including brand planning and commercial advisory board leadership; ensure portal decisions have robust commercial assessments that account for portfolio fit and organizational impact.
  • Deliver assigned-brand marketing materials on time and to expected quality in alignment with company processes and requirements, including contributions to Global Product Strategy, competitive insights, patient-centric deliverables, Target Product Profiles, forecasts, and lifecycle-management strategies.
  • Lead forums for cross-sharing between local markets, gather market input on global deliverables, and support launch-readiness reviews to integrate local insights into global strategy.

About the Company

Amgen

Makes biotech medicines for serious illnesses

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company size
10,001+
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Amgen

See more jobs